Volume 9 Issue 10, Oct 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 9 Issue 10, Oct 2024:
Research Highlight
“Clone-specific” antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers
Dennis Jungherz,Philipp Lückemeier &Marco Herling